Abstract
Antibiotic resistance is an increasing global problem. Surveillance studies are needed to monitor resistance development, to guide local empirical therapy, and to implement timely and adequate countermeasures. To achieve this, surveillance studies must have standardised methodologies, be longitudinal, and cover a sufficiently large and representative population. However, many fall short of these requirements that define good surveillance studies. Moreover, current efforts are dispersed among many, mostly small, initiatives with different objectives. These studies must be tailored to the various reservoirs of antibiotic-resistant bacteria, such as hospitalised patients, nursing homes, the community, animals and food. Two studies that could serve as examples of tailored programmes are the European Antimicrobial Resistance Surveillance System (EARSS), which collects resistance data during the diagnosis of hospitalised patients, and the DANMAP programme, which collects data in the veterinary sector. As already noted by the WHO, genetic studies that include both the typing of isolates and the characterisation of resistance determinants are necessary to understand fully the spread and development of antibiotic resistance.
References
Jan 1, 1977·Advances in Applied Microbiology·T MisatoI Yamaguchi
Apr 1, 1993·Applied and Environmental Microbiology·G W Sundin, C L Bender
Jul 14, 1998·Antimicrobial Agents and Chemotherapy·M A PfallerK Kugler
Apr 20, 1999·Journal of Chemotherapy·D Felmingham, J Washington
Aug 14, 1999·Scandinavian Journal of Infectious Diseases·S Mölstad, O Cars
May 5, 2000·International Journal of Antimicrobial Agents·F Bager
Sep 2, 2000·The Journal of Antimicrobial Chemotherapy·G Kahlmeter
Jan 4, 2001·Journal of Clinical Microbiology·F C TenoverR Williams
Apr 11, 2001·Emerging Infectious Diseases·H M RichetW R Jarvis
Jun 5, 2001·The Journal of Antimicrobial Chemotherapy·J J Snell, D F Brown
Jul 10, 2001·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R BaxA White
Dec 12, 2001·The Pediatric Infectious Disease Journal·P Nilsson, M H Laurell
Jan 5, 2002·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·A MarcheseG C Schito
Jan 5, 2002·Diagnostic Microbiology and Infectious Disease·R N Jones, R Masterton
Jan 11, 2002·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M A Leverstein-van HallJ Verhoef
Jan 22, 2002·Bulletin Du Groupèment International Pour La Recherche Scientifique En Stomatologie & Odontologie·M FonziL Fonzi
May 7, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D L MonnetN Gonzalo
May 23, 2002·Journal of Chemotherapy·H LeblebiciogluUNKNOWN Study Group
May 31, 2002·Journal of Clinical Microbiology·Sylvain BrisseRob J L Willems
Sep 20, 2002·The Journal of Antimicrobial Chemotherapy·David Felmingham
Sep 20, 2002·The Journal of Antimicrobial Chemotherapy·Rafael CantónFernando Baquero
Nov 7, 2002·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control and Prevention (CDC)
Dec 4, 2002·The Journal of Antimicrobial Chemotherapy·Gunnar Kahlmeter, Derek F J Brown
Dec 4, 2002·The Journal of Antimicrobial Chemotherapy·S BronzwaerUNKNOWN EARSS participants
Jan 31, 2003·The Journal of Antimicrobial Chemotherapy·J García-De-LomasC Gimeno
Mar 13, 2003·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·S.L.A.M. BronzwaerM.J.W Sprenger
Apr 19, 2003·Journal of Clinical Microbiology·Stephen MurchanBarry Cookson
Jun 12, 2003·Journal of Chemotherapy·F SorianoF Santos
Oct 18, 2003·Infection·E MeyerF D Daschner
Jun 11, 2004·The Journal of Antimicrobial Chemotherapy·J T Magee
Nov 5, 2004·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·F M Aarestrup
Nov 18, 2005·Biochemical Pharmacology·Jan Verhoef, Ad Fluit
Citations
Aug 19, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David H Lloyd
Nov 11, 2008·Foodborne Pathogens and Disease·A R VieiraH-D Emborg
Dec 17, 2008·Foodborne Pathogens and Disease·Antonio Roberto VieiraHanne-Dorthe Emborg
Mar 14, 2013·International Journal of Environmental Research and Public Health·Vesna FurtulaPatricia A Chambers
Oct 4, 2012·European Urology·Mete ÇekUNKNOWN Global Prevalence Study of Infections in Urology Investigators
Jan 26, 2010·Enfermedades infecciosas y microbiología clínica·Eduardo Aznar-OrovalJoaquín Maíquez-Richart
Sep 29, 2015·Canadian Journal of Microbiology·Devin B Holman, Martin R Chénier
Nov 6, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A van BelkumUNKNOWN European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group on Epidemiological Markers (ESGEM)
Apr 10, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·UNKNOWN European Food Safety Authority--Working Group on Developing Harmonised Schemes for Monitoring Antimicrobial Resistance in Zo
Jul 9, 2016·PloS One·Alison E MatherStuart W J Reid
Jul 6, 2010·The Journal of Hospital Infection·K KaierU Frank
Sep 25, 2016·Annals of Clinical Microbiology and Antimicrobials·Alexander RohdeSascha Al Dahouk
Dec 19, 2007·Bioorganic & Medicinal Chemistry Letters·Marie AufortChristian Girard
Mar 31, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Christy Manyi-LohAnthony Okoh
Jul 19, 2018·Chemistry & Biodiversity·Ensieh Nasli EsfahaniBagher Larijani
Feb 19, 2019·Expert Opinion on Drug Discovery·Anu RaniVipan Kumar
Nov 24, 2019·Applied and Environmental Microbiology·Troy SkworMaggie Stemme
Oct 4, 2012·Journal of the American Animal Hospital Association·Dawn BootheTerri Hatchcock
Apr 4, 2021·Medicina·Sarah Humboldt-Dachroeden, Alberto Mantovani
May 7, 2021·Frontiers in Medicine·Chantal M MorelUNKNOWN Enhanced Surveillance Expert Consensus Group (CANSORT-SCI)